Short TermNew TradeSpot

AVAXAVAX Short Term AI Analysis

DirectionBullish
Confidence65%
Risk Medium

Entry Zones

Optimal13.20
Alternative13.15

Stop Loss

13.10

Take Profit Targets

TP113.30
TP213.35
TP313.40

QUICK TAKE: Price is currently consolidating at 13.21 with mixed signals; immediate bias is neutral to slightly bullish for a potential bounce from support.

ENTRY SETUP:

  • Direction: BUY
  • Entry Price: 13.20
  • Confirmation Needed: A 15m candle closing above 13.25 with increased volume above 200,000
  • Confidence: Medium

RISK MANAGEMENT:

  • Stop Loss: 13.10
  • Target 1: 13.30 (conservative, hours away)
  • Target 2: 13.40 (optimistic, 12-24h away)
  • Risk/Reward: 1:1 to Target 1, 1:2 to Target 2

KEY LEVELS:

  • Immediate Support: 13.17 (15m swing low) and 13.15 (1h support)
  • Immediate Resistance: 13.30 (15m swing high) and 13.35 (1h resistance)

INVALIDATION: This setup fails if price breaks below 13.15 on the 1h timeframe or if bearish momentum increases on the 15m with a close below 13.17.

TIME FOCUS: Short-term perspective suggests a range-bound market with potential for a bullish reversal if support holds; outlook is cautious but opportunistic for intraday gains.

How this analysis is made

Crypto Analysis AI continuously tracks 15,000+ cryptocurrencies across 26 exchanges, scoring each with 100+ technical indicators. The moment an analysis is requested, it crunches live price action, momentum and volume — and, where relevant, market sentiment and funding rates — then lets AI synthesize everything into a clear, actionable plan: direction, entry zones, take-profit targets, stop-loss and a transparent risk read. No paid signals, no gurus — just data and AI, on demand.

Not financial advice. These AI-generated analyses are for informational and educational purposes only — not investment, financial, or trading advice. Crypto trading carries substantial risk and you may lose your capital. Always do your own research and consult a licensed advisor. Past performance does not guarantee future results.